Trials / Conditions / Myeloid Metaplasia
Myeloid Metaplasia
5 registered clinical trials studyying Myeloid Metaplasia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies NCT00807677 | Millennium Pharmaceuticals, Inc. | Phase 1 |
| Completed | A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia NCT00463385 | Celgene | Phase 2 |
| Completed | A Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM) NCT00287261 | Universitaire Ziekenhuizen KU Leuven | Phase 2 |
| Completed | Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED) NCT00086125 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML) NCT00136409 | Dana-Farber Cancer Institute | Phase 2 |